Results 231 to 240 of about 3,006,902 (314)

The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members. [PDF]

Front Endocrinol (Lausanne)
Ludgate S, McGowan A, Moran C, Attanasio R, Žarković M, Nagy EV, Negro R, Papini E, Adler Cohen C, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Ćirić J, Díez JJ, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führer-Sakel D, Galofré JC, Hakala T, Jiskra J, Kopp PA, Krebs M, Kršek M, Kužma M, Lazúrová I, Leenhardt L, Luchytskiy V, Melo M, Metso S, Morgunova T, Niculescu DA, Perić B, Planck T, Poiana C, Marques Puga F, Robenshtok E, Rosselet P, Ruchala M, Riis KR, Shepelkevich A, Tronko MD, Frølich JS, Unuane D, Vardarli I, Visser WE, Vryonidou A, Younes YR, Yurenya E, Perros P, Hegedüs L.   +59 more
europepmc   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Acute schistosomiasis in travellers: outcomes of a short-course therapy. [PDF]

J Travel Med
Clerinx J, Maniewski U, Van Den Broucke S, Soentjens P, Cnops L, Van Esbroeck M, Bottieau E.   +6 more
europepmc   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Narrative Expertise in Oncology: An Integrated Training Model to Advance the Field.

JMIR Cancer
Paul TK, Kaye EC.
europepmc   +1 more source

Mapping and Cataloguing Microbial and Biochemical Determinants of Health: Towards a 'Database of Salutogenic Potential'. [PDF]

Microb Biotechnol
Robinson JM, Brame J, Cando-Dumancela C, Deshmukh S, Fickling NW, Hawken S, Hayward C, Kuhn E, Lee K, Liddicoat C, Ramesh S, Robinson K, Sun X, Breed MF.   +13 more
europepmc   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Cognitive and neural mechanisms of mental imagery supporting creative cognition. [PDF]

Commun Biol
Gu J, Wang X, Liu C, Yang L, Fan J, Sun J, Kenett YN, Qiu J.   +7 more
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma. [PDF]

Sci Rep
Bauer F, Hajiyianni M, Weinhold N, Grözinger M, Kächele J, Menis E, Raab MS, Sauer S, Jauch A, Weber TF, Debic M, Besemer B, Horger M, Afat S, Hoffmann M, Hoffend J, Kraemer D, Graeven U, Ringelstein A, Dürig J, Umutlu L, Schlemmer HP, Goldschmidt H, Maier-Hein K, Delorme S, Mai EK, Wennmann M, Neher P.   +27 more
europepmc   +1 more source